Empress Therapeutics is a biotechnology research company based in Cambridge, Massachusetts. Founded by Flagship Pioneering in 2020, the company utilizes the Empress Chemilogics(TM) platform to generate good medicines quickly by starting with chemistry inside the human body. They create first- or best-in-class oral medicines for a broad range of diseases using novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body. Empress Therapeutics embraces creativity and has a team that participates in activities like the Empress Running Club and festive celebrations.

Empress Therapeutics

Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently drug-like small molecules as a uniquely qualified source of potential drugs.Our mission is to generate transformative drug candidates that get to the clinic faster and cheaper, with a higher probability of success.

COM:EMPRESSTX

Empress Therapeutics

market

industry

website

crunchbase

linkedin

Metrics